Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrochlorothiazide plus loop diuretics in hospitalized decompensated heart failure
2013-001852-36Phase 4Active
- Sponsor
- Sociedad Española de Medicina Interna
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydrochlorothiazide in heart failure (HF) (2 arms), sponsored by Sociedad Española de Medicina Interna. Primary endpoint: Primary efficacy endpoints. Started Nov 2013; status: active.
02
Drugs
hydrochlorothiazide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2013-001852-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001852-36.